Sung-Dong Cho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sung-Dong Cho has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Hyun Jik Kim
Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul, Republic of Korea
3 shared publications Sujin Kim
Department of Otorhinolaryngology Seoul National University College of Medicine Seoul Korea
2 shared publications- Dae Woo Kim
Department of Otorhinolaryngology-Head and Neck Surgery, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea
1 shared publication Dong-Kyu Kim
Department of Otorhinolaryngology-Head and Neck Surgery, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Korea
1 shared publication- Gene Huh
Department of Otolaryngology‐Head and Neck Surgery, St. Vincent's Hospital, College of Medicine The Catholic University of Korea Seoul Republic of Korea
1 shared publication Haeun Shin
Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul, South Korea
1 shared publication
Latest Publications
- Open Access
- 11 January 2026
- Published by Wiley in Clinical & Translational Immunology
- Vol. 15 (1)
Prolonged persistence of tissue‐resident memory cells in the upper airway following SARS ‐ CoV ‐2 infection and vaccination
Objectives: Here, we characterised the diversity and persistence of immunological memory cells—particularly tissue‐resident memory T (T RM ) and B (B RM ) cells—in the nasopharyngeal lymphoid tissues of healthy vaccinated (HV) individuals and those who experienced SARS‐CoV‐2 breakthrough infection (BR). Methods: Nasopharynx (NP) samples were obtained using brushing from HV and BR subjects. Immune cell populations were analysed using transcriptomic profiling and flow cytometry. Results: Transcriptomic profiling revealed that the NP of SARS‐CoV‐2‐infected individuals exhibited distinctive signatures of lymphocyte‐mediated immunity, underscoring its role as a key site for viral invasion and immune activation. Effector memory CD4+ and CD8+ T (T EM ) cells, along with non‐germinal center (GC) B cells, predominated in the NP. Although overall frequencies of memory T cells were comparable between HV and BR groups, CD4+ T EM and GC B cells were significantly enriched in the NP of BR individuals at least 1 year post infection. Notably, over 80% of CD4+ T EM and 40% of CD8+ T EM cells were T RM , and more than 30% of memory B cells exhibited a B RM phenotype. These populations of CD4+, CD8+ T RM and B RM persisted in the NP for over 2 years following SARS‐CoV‐2 infection or vaccination. In particular, CD4+ T RM cells were significantly more abundant and durably maintained in the NP mucosa of BR individuals. Conclusion: Our findings identify the nasopharynx as a key site of long‐lived immunological memory, marked by persistent T RM and B RM cells after SARS‐CoV‐2 exposure.
- 11 January 2026
- Published by Wiley in Clinical & Translational Immunology
- Vol. 15 (1)
Open AccessProlonged persistence of tissue‐resident memory cells in the upper airway following SARS ‐ CoV ‐2 infection and vaccination
Objectives: Here, we characterised the diversity and persistence of immunological memory cells—particularly tissue‐resident memory T (T RM ) and B (B RM ) cells—in the nasopharyngeal lymphoid tissues of healthy vaccinated (HV) individuals and those who experienced SARS‐CoV‐2 breakthrough infection (BR). Methods: Nasopharynx (NP) samples were obtained using brushing from HV and BR subjects. Immune cell populations were analysed using transcriptomic profiling and flow cytometry. Results: Transcriptomic profiling revealed that the NP of SARS‐CoV‐2‐infected individuals exhibited distinctive signatures of lymphocyte‐mediated immunity, underscoring its role as a key site for viral invasion and immune activation. Effector memory CD4+ and CD8+ T (T EM ) cells, along with non‐germinal center (GC) B cells, predominated in the NP. Although overall frequencies of memory T cells were comparable between HV and BR groups, CD4+ T EM and GC B cells were significantly enriched in the NP of BR individuals at least 1 year post infection. Notably, over 80% of CD4+ T EM and 40% of CD8+ T EM cells were T RM , and more than 30% of memory B cells exhibited a B RM phenotype. These populations of CD4+, CD8+ T RM and B RM persisted in the NP for over 2 years following SARS‐CoV‐2 infection or vaccination. In particular, CD4+ T RM cells were significantly more abundant and durably maintained in the NP mucosa of BR individuals. Conclusion: Our findings identify the nasopharynx as a key site of long‐lived immunological memory, marked by persistent T RM and B RM cells after SARS‐CoV‐2 exposure.
- Open Access
- 1 January 2023
- Published by XMLink in Immune Network
- Vol. 23 (1) , e11
Roles of Virtual Memory T Cells in Diseases
Seok J, et al. Immune Netw. 2023 Feb;23(1):e11. https://doi.org/10.4110/in.2023.23.e11
- 1 January 2023
- Published by XMLink in Immune Network
- Vol. 23 (1) , e11
Open AccessRoles of Virtual Memory T Cells in Diseases
Seok J, et al. Immune Netw. 2023 Feb;23(1):e11. https://doi.org/10.4110/in.2023.23.e11
- 8 September 2021
- Published by Wiley in The Laryngoscope
- Vol. 132 (5) , 1061-1068
Application and Efficiency of Transnasal Humidified Rapid‐Insufflation Ventilatory Exchange in Laryngeal Microsurgery
Objectives/Hypothesis: This study aimed to analyze the feasibility of transnasal humidified rapid‐insufflation ventilatory exchange (THRIVE) during laryngeal microsurgery (LMS) and investigated its efficiency and application according to the location of the lesion.Study Design: Retrospective chart review.Methods: Patients over 20 years of age who underwent LMS without underlying cardiac, pulmonary, or cerebrovascular disease were retrospectively reviewed. Overall, 54 patients with endotracheal intubation (ETI) and 44 patients with THRIVE were included. The operation and anesthesia time, induction and emergence time, oxygen saturation (SpO2), and transcutaneous carbon dioxide (TcCO2) levels were analyzed and compared between the two ventilation methods according to disease subsite.Results: Compared with ETI, patients with THRIVE presented reduced operation time (16.3 ± 9.69 min vs. 21.9 ± 12.0 min), anesthesia time (33.6 ± 11.4 min vs. 45.4 ± 13.9 min), emergence time (6.73 ± 2.49 min vs. 8.52 ± 3.17 min), without significant decreases in SpO2 but with increased TcCO2 (10.9 ± 6.12% vs. 7.33 ± 3.86%). Comparing THRIVE to ETI for lesions at the glottis yielded similar findings, which were particularly more significant. However, lesions above the glottis presented no significant difference for any parameters between THRIVE and ETI groups. Lesions involving multiple subsites and prolonged operation time were risk factors for the intraoperative conversion of ventilation method.Conclusion: THRIVE is reliable for maintaining oxygenation during LMS and is efficient in reducing the operation and emergence times, leading to shorter anesthesia time, especially for lesions at the glottis. However, caution is required administering THRIVE, when lesion involves multiple subsites, and when operation time is prolonged.Level of Evidence: 3 Laryngoscope, 132:1061–1068, 2022
- 8 September 2021
- Published by Wiley in The Laryngoscope
- Vol. 132 (5) , 1061-1068
Application and Efficiency of Transnasal Humidified Rapid‐Insufflation Ventilatory Exchange in Laryngeal Microsurgery
Objectives/Hypothesis: This study aimed to analyze the feasibility of transnasal humidified rapid‐insufflation ventilatory exchange (THRIVE) during laryngeal microsurgery (LMS) and investigated its efficiency and application according to the location of the lesion.Study Design: Retrospective chart review.Methods: Patients over 20 years of age who underwent LMS without underlying cardiac, pulmonary, or cerebrovascular disease were retrospectively reviewed. Overall, 54 patients with endotracheal intubation (ETI) and 44 patients with THRIVE were included. The operation and anesthesia time, induction and emergence time, oxygen saturation (SpO2), and transcutaneous carbon dioxide (TcCO2) levels were analyzed and compared between the two ventilation methods according to disease subsite.Results: Compared with ETI, patients with THRIVE presented reduced operation time (16.3 ± 9.69 min vs. 21.9 ± 12.0 min), anesthesia time (33.6 ± 11.4 min vs. 45.4 ± 13.9 min), emergence time (6.73 ± 2.49 min vs. 8.52 ± 3.17 min), without significant decreases in SpO2 but with increased TcCO2 (10.9 ± 6.12% vs. 7.33 ± 3.86%). Comparing THRIVE to ETI for lesions at the glottis yielded similar findings, which were particularly more significant. However, lesions above the glottis presented no significant difference for any parameters between THRIVE and ETI groups. Lesions involving multiple subsites and prolonged operation time were risk factors for the intraoperative conversion of ventilation method.Conclusion: THRIVE is reliable for maintaining oxygenation during LMS and is efficient in reducing the operation and emergence times, leading to shorter anesthesia time, especially for lesions at the glottis. However, caution is required administering THRIVE, when lesion involves multiple subsites, and when operation time is prolonged.Level of Evidence: 3 Laryngoscope, 132:1061–1068, 2022
- Open Access
- 1 May 2021
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Clinical and Experimental Otorhinolaryngology
- Vol. 14 (2) , 235-239
Earmold Foreign Bodies in the Middle Ear Necessitating Surgical Removal: Why Otology Specialists Should Screen Candidates for Hearing Aids
- 1 May 2021
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Clinical and Experimental Otorhinolaryngology
- Vol. 14 (2) , 235-239
Open AccessEarmold Foreign Bodies in the Middle Ear Necessitating Surgical Removal: Why Otology Specialists Should Screen Candidates for Hearing Aids
- Open Access
- 21 August 2020
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Korean Journal of Otorhinolaryngology-Head and Neck Surgery
- Vol. 63 (8) , 381-385
A Case of 40-Year-Old Male with Onodi Cell Mucocele
Sphenoethmoidal (Onodi) cells originate from the ethmoid sinus and are located at the posterior and lateral direction. The obstruction of the sinus ostium leads to the accumulation of mucous fluid and eventually leads to the formation of a mucocele. Onodi cell mucoceles can cause visual loss or disturbance due to the adjacency to the orbital apex. Here we report a case of Onodi cell mucocele with a visual field disturbance, where the patient underwent an endoscopic sinus surgery 12 days after the initial symptom. After 21 days of onset, the subjective symptom started to subside. For Onodi cell mucocele patients with visual disturbance, we recommend rapid diagnosis with computed tomography and early marsupialization of the mucocele.
- 21 August 2020
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Korean Journal of Otorhinolaryngology-Head and Neck Surgery
- Vol. 63 (8) , 381-385
Open AccessA Case of 40-Year-Old Male with Onodi Cell Mucocele
Sphenoethmoidal (Onodi) cells originate from the ethmoid sinus and are located at the posterior and lateral direction. The obstruction of the sinus ostium leads to the accumulation of mucous fluid and eventually leads to the formation of a mucocele. Onodi cell mucoceles can cause visual loss or disturbance due to the adjacency to the orbital apex. Here we report a case of Onodi cell mucocele with a visual field disturbance, where the patient underwent an endoscopic sinus surgery 12 days after the initial symptom. After 21 days of onset, the subjective symptom started to subside. For Onodi cell mucocele patients with visual disturbance, we recommend rapid diagnosis with computed tomography and early marsupialization of the mucocele.
- Open Access
- 1 January 2018
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 10 (5) , 490-502
Two-Track Medical Treatment Strategy According to the Clinical Scoring System for Chronic Rhinosinusitis
Kim DK, et al. Allergy Asthma Immunol Res. 2018 Sep;10(5):490-502. https://doi.org/10.4168/aair.2018.10.5.490
- 1 January 2018
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 10 (5) , 490-502
Open AccessTwo-Track Medical Treatment Strategy According to the Clinical Scoring System for Chronic Rhinosinusitis
Kim DK, et al. Allergy Asthma Immunol Res. 2018 Sep;10(5):490-502. https://doi.org/10.4168/aair.2018.10.5.490